doi: 10.1161/CIR.0b013e3181d34114.
Epub 2010 Feb 23.
Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College of Cardiology Foundation
- PMID: 20179252
- DOI: 10.1161/CIR.0b013e3181d34114
Item in Clipboard
Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College of Cardiology Foundation
Circulation.
.
No abstract available
Similar articles
-
Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College Of Cardiology Foundation.J Am Coll Cardiol. 2010 Apr 27;55(17):1885-94. doi: 10.1016/j.jacc.2010.02.014. J Am Coll Cardiol. 2010. PMID: 20413044 No abstract available.
-
A perspective on the American Heart Association/American College of Cardiology science advisory on thiazolidinedione drugs and cardiovascular risks.Circ Cardiovasc Qual Outcomes. 2010 May;3(3):221-2. doi: 10.1161/CIRCOUTCOMES.110.936070. Epub 2010 Feb 24. Circ Cardiovasc Qual Outcomes. 2010. PMID: 20181986 No abstract available.
-
Diabetes drug safety update: Avandia and your heart.Johns Hopkins Med Lett Health After 50. 2010 Jun;22(4):1-2, 7. Johns Hopkins Med Lett Health After 50. 2010. PMID: 20572316 No abstract available.
-
Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.Circulation. 2003 Dec 9;108(23):2941-8. doi: 10.1161/01.CIR.0000103683.99399.7E. Circulation. 2003. PMID: 14662691 Review. No abstract available.
-
Thiazolidinediones in type 2 diabetes: a cardiology perspective.Ann Pharmacother. 2008 Oct;42(10):1466-74. doi: 10.1345/aph.1K666. Epub 2008 Sep 2. Ann Pharmacother. 2008. PMID: 18698014 Review.
Cited by
-
Effects of rosiglitazone on the configuration of action potentials and ion currents in canine ventricular cells.Br J Pharmacol. 2011 Jun;163(3):499-509. doi: 10.1111/j.1476-5381.2011.01215.x. Br J Pharmacol. 2011. PMID: 21232044 Free PMC article.
-
Selective block of K(ATP) channels: why the anti-diabetic sulphonylureas and rosiglitazone have more in common than we thought.Br J Pharmacol. 2012 Sep;167(1):23-5. doi: 10.1111/j.1476-5381.2012.01990.x. Br J Pharmacol. 2012. PMID: 22506686 Free PMC article.
-
Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancer.Genome Med. 2012 Apr 30;4(4):32. doi: 10.1186/gm331. Genome Med. 2012. PMID: 22546357 Free PMC article.
-
Setting the record straight on TIDE: a lost opportunity for patients with diabetes.Diabetologia. 2013 Sep;56(9):1884-7. doi: 10.1007/s00125-013-2959-0. Epub 2013 Jun 6. Diabetologia. 2013. PMID: 23740195
-
Developing therapies for the metabolic syndrome: challenges, opportunities, and… the unknown.Ther Adv Endocrinol Metab. 2010 Apr;1(2):89-94. doi: 10.1177/2042018810375812. Ther Adv Endocrinol Metab. 2010. PMID: 23148153 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
